Section III: GVH Responses Biology of Graft-versus-Host Responses: Recent Insights

摘要

INTRODUCTION Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for many malignant and nonmalignant hematological diseases. The curative effect of allo-HSCT results from both the chemotherapy/ radiation in the conditioning regimen and the donor T-mediated graft-versus-host (GVH) response against the malignancy known as a graft-versus-leukemia (GVL) effect. In most cases, the GVH response is not limited against the malignant cells but is also mediated against host epithelial cells, causing graft-versus-host disease (GVHD).